Mediating BRAF-mutant melanoma resistance
Drug Target Review
FEBRUARY 26, 2024
Dr Alani also directs a clinical program at Boston Medical Center focused on patients with melanoma and other high-risk skin cancers and has been recognized as a 2024 Boston Magazine and Castle Connolly Top Doctor. Dr Alani received her M.D. degree with Honors and Distinction in Research from the University of Michigan.
Let's personalize your content